{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:48:34Z","timestamp":1782287314138,"version":"3.54.5"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 17-year-old boy with Von Hippel\u2013Lindau syndrome presented with hypertension, raised plasma catecholamines, and MRI findings of a new pancreatic tail lesion and 2 stable right adrenal lesions concerning for functional neuroendocrine tumors. A <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT demonstrated intense tracer avidity within the pancreatic lesion with minimal uptake in the adrenal lesions. Conversely, a <jats:sup>123<\/jats:sup>I-MIBG SPECT\/CT study demonstrated high-grade tracer uptake within the adrenal lesions, with no significant uptake appreciated in the pancreatic lesion. The adrenal lesions were resected, and pathology was consistent with pheochromocytoma. Plasma catecholamines returned to within the normal range and hypertension resolved.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005308","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:09:14Z","timestamp":1718125754000},"page":"e451-e452","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of 68Ga-DOTATATE PET\/CT and 123I-MIBG SPECT\/CT in the Imaging of Functional Pheochromocytoma in an Adolescent Patient With Von Hippel\u2013Lindau Syndrome"],"prefix":"10.1097","volume":"49","author":[{"given":"Karan","family":"Singh","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Sandler","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Hahn","sequence":"additional","affiliation":[{"name":"Nephrology, The Children\u2019s Hospital at Westmead, Westmead, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David KV","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(04)15957-6","article-title":"Von Hippel\u2013Lindau disease","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015458.2010.11680587","article-title":"Phaeochromocytoma: state-of-the-art","volume":"110","year":"2010","journal-title":"Acta Chir Belg"},{"key":"bib4-20250621","first-page":"353","article-title":"Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma","volume":"7","year":"1993","journal-title":"J Hum Hypertens"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jc.2009-2604","article-title":"123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"(68)Ga-DOTATATE and (18)F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","year":"2016","journal-title":"Cancer Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13139-015-0331-7","article-title":"Diagnostic performance of (68)Ga-DOTATATE PET\/CT, (18)F-FDG PET\/CT and (131)I-MIBG scintigraphy in mapping metastatic pheochromocytoma and paraganglioma","volume":"49","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2214\/AJR.21.26071","article-title":"Sporadic primary pheochromocytoma: a prospective intraindividual comparison of six imaging tests (CT, MRI, and PET\/CT using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA)","volume":"218","year":"2022","journal-title":"AJR Am J Roentgenol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:03:10Z","timestamp":1750532590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005308","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}